• Fund Type: FCP
  • Objective: Greater China
  • Asset Class: Equity
  • Geographic Focus: Greater China

UBS Lux Equity Fund - Greater China USD

+ Add to Watchlist

UBSGRPA:LX

104.26 SGD 0.14 0.13%

As of 00:59:30 ET on 12/24/2014.

Snapshot for UBS Lux Equity Fund - Greater China USD (UBSGRPA)

Year To Date: +4.37% 3-Month: +0.82% 3-Year: +11.84% 52-Week Range: 89.69 - 108.24
1-Month: -3.34% 1-Year: +6.27% 5-Year: - Beta vs LUXXX: 0.50

Mutual Fund Chart for UBSGRPA

No chart data available.
  • UBSGRPA:LX 104.26
  • 1M
  • 1Y
Interactive UBSGRPA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UBSGRPA

UBS (Lux) Equity Fund - Greater China (USD) is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests primarily in equities of leading companies domiciled or cheifly active in China, Hong Kong and Taiwan

Inception Date: 04-14-2010 Telephone: 352-44-10-10-1 Tel
Managers: BIN SHI / HAI HUANG
Web Site: www.ubs.com

Fundamentals for UBSGRPA

NAV (on 2014-12-24) 104.26
Assets (M) (on 2014-12-24) 563.30
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for UBSGRPA

No dividends reported

Fees & Expenses for UBSGRPA

Front Load 2.00
Back Load -
Current Mgmt Fee 1.87
Redemption Fee -
12b1 Fee -
Expense Ratio 2.39

Top Fund Holdings for UBSGRPA

Filing Date: 09/30/2014
Name Position Value % of Total
Tencent Holdings Ltd 3,684,800 54,810,383 8.941%
Shenzhen International Holding 25,799,909 35,220,131 5.745%
Industrial & Commercial Bank o 55,485,810 34,585,513 5.642%
Taiwan Semiconductor Manufactu 7,338,673 28,949,876 4.722%
TAL Education Group 817,100 28,565,816 4.660%
China Construction Bank Corp 27,207,450 19,061,351 3.109%
Lijun International Pharmaceut 34,796,000 16,759,762 2.734%
Anhui Gujing Distillery Co Ltd 5,584,658 16,045,863 2.617%
Sino Biopharmaceutical Ltd 16,080,000 16,007,830 2.611%
CNOOC Ltd 8,968,000 15,383,911 2.509%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil